Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.
about
Early interventions in risk groups for schizophrenia: what are we waiting for?Stress weakens prefrontal networks: molecular insults to higher cognitionAttachment, Neurobiology, and Mentalizing along the Psychosis ContinuumTargeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersHow Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of PsychosisSchizophrenia risk from complex variation of complement component 4Motion-related artifacts in structural brain images revealed with independent estimates of in-scanner head motionInflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualizationTractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sampleAlterations in the hippocampus and thalamus in individuals at high risk for psychosis.Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia.N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth.The Function Biomedical Informatics Research Network Data RepositoryBrain imaging during the transition from psychosis prodrome to schizophrenia.Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI studyA critique of the "ultra-high risk" and "transition" paradigm.Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study.Evolution of structural abnormalities in the rat brain following in utero exposure to maternal immune activation: A longitudinal in vivo MRI study.SchizConnect: Mediating neuroimaging databases on schizophrenia and related disorders for large-scale integration.Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic StressAltered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic DisordersPaliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca(2+) Influx and Regulation of SIRT1/miR-134 Signal Pathway.Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk StudyDelinquency, depression, and psychosis among adolescents in foster care: what holds three heads together?Functional Connectivity Anomalies in Adolescents with Psychotic SymptomsConnectome-wide network analysis of youth with Psychosis-Spectrum symptoms.Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies.Microglial activation and progressive brain changes in schizophrenia.Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosisDynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Is neuroimaging clinically useful in subjects at high risk for psychosis?Brain Biomarkers of Vulnerability and Progression to Psychosis
P2860
Q26747545-9831522D-DBF7-46DD-B0F2-205E3CBF6C7BQ26781227-95BF3793-CC09-4320-961D-1F54DF8A128DQ28069770-064ED25F-F0C2-4DFE-9CCB-16BEDE076A62Q28076907-6770ABBD-F806-4CA3-8969-8DD2CBCAB217Q28087255-EE62479B-2D52-47CA-93E8-EEF0C8A2EDFBQ28272545-5F6C1E2D-AE82-415B-B052-A8A0D7EC33BDQ28583749-F5208E38-E458-4639-A8E7-0C91D8A4150DQ30236016-2F4EA92E-183E-42CB-BDBE-872562050EA0Q30357824-EFF10A53-BD05-4B41-9ADB-DD3A2319265EQ30368928-676F01A3-0F5A-491E-AD34-1A66DE7E8A61Q30381309-F463ED43-B285-4560-B51B-4754F419881DQ30383068-2FB07837-28FC-404A-BA25-B6DAB9529691Q30391026-6F0342BB-12E8-4D2E-81F3-9E8F391FA9F5Q30679446-B237AAAF-1905-4E6A-8AE0-0967CEE1038AQ30938447-416722CB-C980-40B2-AFEF-A34F901C8F04Q33635522-2AF1F894-72B6-4C0E-B909-FC5F55DDE16DQ33670654-26971C26-65B5-45E9-B30F-728F9905E1B9Q33707483-7A6FFA37-033B-44EB-B8D0-A49BE1BF250FQ33718930-A1083310-8FAF-40EB-90DB-83875FDF03FCQ34483469-4E52F4A2-A43E-4FC5-BEFB-7AFDF343C4BEQ34681347-C47128DE-2DFE-4F9D-A09A-1C527097AFB7Q35046682-E4860946-DD10-4C4D-87BB-4F9811254385Q35603078-68B5BFB9-32DC-4525-82F1-4A4072ABF92BQ35621468-8EFF9BE9-8D2E-431D-BB2A-8E335A316F18Q35657340-7DC95034-DE7F-4202-BE48-A6B06E3CA10FQ36066670-846917EC-0DDF-4D8D-B66B-D74D70D80EB8Q36148454-2231C8E8-4DC5-4EDC-8B16-7D0B45C43919Q36216975-47486EA4-A00B-415D-A288-FB11F233F9DCQ36260876-50C7F321-D727-428B-8DE9-61C73AAF811BQ36296795-18D9D934-2E51-47AD-BFE7-D650607397A8Q36348922-788F8C7F-1863-4945-B69A-812E900BA7E1Q36546971-0FFA2E0F-127A-4452-AD83-2C8BC7DE6C39Q36665332-1CA51CC9-C201-4CB7-90DA-6D42085BE609Q36683838-72FDA867-B177-4CCF-B6AD-2040F113C7ADQ36766806-FF56C594-7E43-49B8-9EED-320C860E4E9DQ36813471-7DD5B16A-491B-4507-8F95-DEA351C747E8Q36858411-BEFCBEC6-B781-45DE-8CD6-6E5DB0C8616BQ36910682-67F11AF3-ED5D-4A3D-9AB7-636882170879Q37015339-48EC9A52-8D79-40B8-9B3E-A499A4A1ACBFQ37124940-791E9BBC-22E0-4DDA-AD7F-1DF114807F21
P2860
Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Progressive reduction in corti ...... uth at elevated clinical risk.
@ast
Progressive reduction in corti ...... uth at elevated clinical risk.
@en
Progressive reduction in corti ...... uth at elevated clinical risk.
@nl
type
label
Progressive reduction in corti ...... uth at elevated clinical risk.
@ast
Progressive reduction in corti ...... uth at elevated clinical risk.
@en
Progressive reduction in corti ...... uth at elevated clinical risk.
@nl
prefLabel
Progressive reduction in corti ...... uth at elevated clinical risk.
@ast
Progressive reduction in corti ...... uth at elevated clinical risk.
@en
Progressive reduction in corti ...... uth at elevated clinical risk.
@nl
P2093
P2860
P50
P921
P1476
Progressive reduction in corti ...... uth at elevated clinical risk.
@en
P2093
Aron Jacobson
Barbara Cornblatt
Carrie E Bearden
Clark Jeffries
Daniel H Mathalon
Daqiang Sun
Diana Perkins
Elaine Walker
Ming Tsuang
P2860
P304
P356
10.1016/J.BIOPSYCH.2014.05.023
P407
P577
2014-06-12T00:00:00Z